Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression

M Clendenning; F Macrae; M Walsh; RJ Walters; SN Thibodeau; SR Gunawardena; JD Potter; RW Haile; S Gallinger; JL Hopper; MA Jenkins; C Rosty; JP Young; DD Buchanan

Journal article

Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression

M Clendenning, F Macrae, M Walsh, RJ Walters, SN Thibodeau, SR Gunawardena, JD Potter, RW Haile, S Gallinger, JL Hopper, MA Jenkins, C Rosty, JP Young, DD Buchanan

Clinical Genetics | WILEY-BLACKWELL | Published : 2013

DOI: 10.1111/cge.12011

University of Melbourne Researchers

Mark Clendenning Author

Finlay Macrae Author

Mark Jenkins Author

Christophe Rosty Author

Related Projects (1)

COMPREHENISVE MODEL FOR COLORECTAL CANCER RISK

I am a genetic epidemiologist focused on bowel cancer risk. I will develop a comprehensive model to estimate individual cancer risk by study..

Grants

Awarded by National Cancer Institute

Citation metrics

8Scopus

7Web of Science

8Dimensions

Keywords

Women'S Health

Genetics

Colo-Rectal Cancer

3202 Clinical Sciences

Cancer

Genetics & Heredity

32 Biomedical and Clinical Sciences

Colorectal Cancer Family Registry

Life Sciences & Biomedicine

3105 Genetics

31 Biological Sciences